Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.
PHASE1CompletedINTERVENTIONAL
Enrollment
58
Participants
Timeline
Start Date
October 31, 2004
Primary Completion Date
December 31, 2005
Study Completion Date
December 31, 2006
Conditions
Acute Myocardial Infarction
Interventions
DRUG
Intensive insulin therapy
Trial Locations (2)
30322
Emory University Hospital, Atlanta
30329
Emory Crawford Long Hospital, Atlanta
All Listed Sponsors
lead
Emory University
OTHER
NCT00209144 - Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction. | Biotech Hunter | Biotech Hunter